News

Heartflow, Bain Capital

Bain Capital-backed Heartflow valued at $2.27 billion in solid Nasdaq debut
By Rishab Shaju and Ateev Bhandari (Reuters) -Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, as the IPO market gathers momentum and outrides tariff worries.
Bain Capital backed Heartflow surges on public debut
Heartflow (NASDAQ:HTFL), a MedTech firm backed by private equity firms including Bain Capital, climbed ~50% on its first trading session as a public company on Friday. On Thursday evening, the Mountain View,
Bain Capital-backed Heartflow prices $317m IPO
Heartflow is advancing coronary care by transforming coronary artery disease into a screenable, diagnosable, and manageable condition.
Bain Capital-backed Heartflow eyes $1.32 billion valuation as medtech IPOs rebound
Medical technology company Heartflow said on Friday it was targeting a valuation of up to $1.32 billion in its U.S. initial public offering, more than three years after its previous attempt to go public fell through.
Heartflow shares surge in Nasdaq debut
Shares of Heartflow opened at $28 on Friday, jumping over 47% above the initial public offering price of $19 per share in their Nasdaq debut. This opening price valued the medical technology company at $2.
Bain Capital-backed Heartflow valued at $2.27B in solid Nasdaq debut
Medtech firm Heartflow was valued at $2.27 billion on Friday, with its shares surging 47.4% in the Nasdaq debut, as the IPO market gathers momentum and outrides tariff worries. The shares opened at $28 and went as high as $31.
Bain Capital-backed Heartflow targets $1.5 billion valuation in upsized US IPO
Medical technology company Heartflow said on Wednesday it was targeting a valuation of up to $1.46 billion in its upsized initial public offering in the United States, indicating robust investor demand.
Medtech Heartflow valued at $2.27 billion in solid Nasdaq debut
(Reuters) -Heartflow shares surged 47.4% in their Nasdaq debut on Friday, giving the medtech firm a valuation of $2.27 billion, as the IPO market gathers momentum and outrides tariff worries. The stock opened at $28,

Heartflow (HTFL) Soars 66% on IPO on Strong Investor Confidence

We recently published 10 Stocks with Eye-Popping Gains; 5 Jump to New Highs. Heartflow, Inc. (NASDAQ:HTFL) is one of the best ...

Heartflow stock listing and IPO date draw near: AI-powered medtech aims for $1.3 billion valuation

Backed by Bain Capital, the health technology startup makes 3D models of people's hearts to help diagnose diseases. Here's ...
Devdiscourse10d

Innovations and Changes in the Health Sector

Toledo's profit forecast boost, Heartflow's IPO target, concerns about sucralose and cancer treatment, Trump's call for ...
BioWorld2y

Bain pumps $215M into Heartflow as series F lead investor

Heartflow Inc. is feeling the love of investors again as it closed a $215 series F financing round led by Bain Capital Life Sciences. The round marks a return to the equity markets after several ...